Twinlab Consolidated Holdings, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 18, 2019 at 03:06 pm EST
Share
Twinlab Consolidated Holdings, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was USD 19.851 million compared to USD 14.933 million a year ago. Operating loss was USD 3.835 million compared to USD 4.024 million a year ago. Net loss was USD 3.216 million compared to USD 8.713 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.03 a year ago. Diluted loss per share from continuing operations was USD 0.02 compared to USD 0.03 a year ago. For the nine months, sales was USD 57.558 million compared to USD 56.259 million a year ago. Operating loss was USD 9.014 million compared to USD 10.625 million a year ago. Net loss was USD 16.542 million compared to USD 19.410 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.08 a year ago.
Twinlab Consolidated Holdings, Inc. is a marketer, distributor and direct-to-consumer retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty store retailers, on-line retailers, and websites. Internationally, the Company markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Through NutraScience Labs, it also provides services between private label distributors and contract manufacturers. Its services business involved the facilitation of manufacture of custom products. Its products include vitamins, minerals, resveratrol, collagen, keratin, skincare and sports nutrition products primarily under the Twinlab, Reserveage and ResVitale brands. It also markets and sells diet and energy products under the Metabolife brand and a full line of herbal teas under the Alvita brand.